Walleye Capital LLC Sells 12,077 Shares of Ryan Specialty Holdings Inc. $RYAN

Key Points

• Walleye Capital LLC sold 12,077 shares of Ryan Specialty Holdings Inc., reducing its stake by 70.4%, leaving it with 5,090 shares valued at approximately $376,000 at the end of the quarter.
• Ryan Specialty reported a quarterly EPS of $0.66 and a revenue of $855.17 million, surpassing analysts' estimates and showcasing a 23% year-over-year growth.
• The company's dividend payout ratio is currently at 137.14%, with a quarterly dividend of $0.12, representing an annual yield of 0.9%.

Walleye Capital LLC lessened its stake in Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 70.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,090 shares of the company's stock after selling 12,077 shares during the quarter. Walleye Capital LLC's holdings in Ryan Specialty were worth $376,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of RYAN. Hsbc Holdings PLC grew its stake in Ryan Specialty by 16.4% in the 4th quarter. Hsbc Holdings PLC now owns 3,654 shares of the company's stock valued at $234,000 after buying an additional 514 shares in the last quarter. Susquehanna International Group LLP grew its stake in Ryan Specialty by 31.1% in the 4th quarter. Susquehanna International Group LLP now owns 39,593 shares of the company's stock valued at $2,540,000 after buying an additional 9,393 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in Ryan Specialty by 2.5% in the 4th quarter. The Manufacturers Life Insurance Company now owns 85,528 shares of the company's stock valued at $5,487,000 after buying an additional 2,119 shares in the last quarter. Northern Trust Corp grew its stake in Ryan Specialty by 20.5% in the 4th quarter. Northern Trust Corp now owns 891,112 shares of the company's stock valued at $57,174,000 after buying an additional 151,391 shares in the last quarter. Finally, Aptus Capital Advisors LLC purchased a new position in Ryan Specialty in the 4th quarter valued at approximately $334,000. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Ryan Specialty Stock Performance

NYSE RYAN opened at $55.42 on Wednesday. Ryan Specialty Holdings Inc. has a 52-week low of $55.14 and a 52-week high of $77.16. The company has a debt-to-equity ratio of 2.88, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market capitalization of $14.62 billion, a P/E ratio of 158.36, a P/E/G ratio of 1.57 and a beta of 0.63. The company has a fifty day moving average of $62.17 and a 200-day moving average of $66.92.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.66 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.66. The company had revenue of $855.17 million during the quarter, compared to the consensus estimate of $837.52 million. Ryan Specialty had a net margin of 6.81% and a return on equity of 48.70%. The firm's revenue was up 23.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.58 EPS. As a group, equities research analysts predict that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 26th. Shareholders of record on Tuesday, August 12th were paid a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $0.48 annualized dividend and a yield of 0.9%. Ryan Specialty's payout ratio is currently 137.14%.

Wall Street Analyst Weigh In

RYAN has been the subject of a number of recent research reports. Morgan Stanley reduced their price objective on shares of Ryan Specialty from $71.00 to $68.00 and set an "overweight" rating for the company in a research note on Monday, August 18th. The Goldman Sachs Group upgraded shares of Ryan Specialty from a "neutral" rating to a "buy" rating and boosted their price target for the company from $74.00 to $81.00 in a research report on Tuesday, May 13th. Barclays reduced their price target on shares of Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating for the company in a research report on Monday, July 7th. Wall Street Zen upgraded shares of Ryan Specialty from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. Finally, UBS Group reduced their price target on shares of Ryan Specialty from $84.00 to $80.00 and set a "buy" rating for the company in a research report on Monday, August 4th. Nine research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, Ryan Specialty has a consensus rating of "Moderate Buy" and an average price target of $74.83.

Insiders Place Their Bets

In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,377 shares of the business's stock in a transaction on Friday, June 13th. The shares were sold at an average price of $65.84, for a total value of $946,581.68. Following the completion of the sale, the executive vice president directly owned 1,117 shares of the company's stock, valued at $73,543.28. The trade was a 92.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 52.21% of the stock is owned by corporate insiders.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.